应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
VTYX Ventyx Biosciences, Inc.
交易中 01-20 12:45:16 EST
13.86
-0.03
-0.22%
最高
13.88
最低
13.85
成交量
102.63万
今开
13.86
昨收
13.89
日振幅
0.22%
总市值
9.94亿
流通市值
7.42亿
总股本
7,175万
成交额
1,422万
换手率
1.92%
流通股本
5,356万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Piper Sandler下调Ventyx Biosciences评级至中性 目标价降至14美元
美股速递 · 01-08
Piper Sandler下调Ventyx Biosciences评级至中性 目标价降至14美元
礼来将以12亿美元收购药物开发商Ventyx，加码自身免疫领域
格隆汇 · 01-08
礼来将以12亿美元收购药物开发商Ventyx，加码自身免疫领域
礼来(LLY.US)确认以每股14美元收购Ventyx Biosciences(VTYX.US)
智通财经 · 01-08
礼来(LLY.US)确认以每股14美元收购Ventyx Biosciences(VTYX.US)
特定情形下合并终止，Ventyx Biosciences需向礼来支付4400万美元解约费
美股速递 · 01-08
特定情形下合并终止，Ventyx Biosciences需向礼来支付4400万美元解约费
礼来收购Ventyx Biosciences以推进炎症介导疾病口服疗法研发
美股速递 · 01-08
礼来收购Ventyx Biosciences以推进炎症介导疾病口服疗法研发
异动解读 | 礼来拟超10亿美元收购，Ventyx Biosciences盘中大涨36.72%
异动解读 · 01-07
异动解读 | 礼来拟超10亿美元收购，Ventyx Biosciences盘中大涨36.72%
Ventyx Biosciences盘初一度涨超50%！据悉礼来接近达成以超10亿美元收购该公司的交易
老虎资讯综合 · 01-07
Ventyx Biosciences盘初一度涨超50%！据悉礼来接近达成以超10亿美元收购该公司的交易
美股异动｜礼来据称接近达成以超10亿美元收购Ventyx的交易，后者盘前飙升70%
格隆汇 · 01-07
美股异动｜礼来据称接近达成以超10亿美元收购Ventyx的交易，后者盘前飙升70%
异动解读 | 礼来拟超10亿美元收购，Ventyx Biosciences盘前大涨69.25%
异动解读 · 01-07
异动解读 | 礼来拟超10亿美元收购，Ventyx Biosciences盘前大涨69.25%
盘前异动｜稀土概念股走强，Critical Metals涨超11%；贵金属板块普跌，金田跌近4%
老虎资讯综合 · 01-07
盘前异动｜稀土概念股走强，Critical Metals涨超11%；贵金属板块普跌，金田跌近4%
美股异动｜Ventyx Biosciences夜盘飙升66%，据称公司将获礼来以超10亿美元收购
格隆汇 · 01-07
美股异动｜Ventyx Biosciences夜盘飙升66%，据称公司将获礼来以超10亿美元收购
美股夜盘 | SanDisk续涨2%，Strategy涨近7%；Ventyx涨超66%，报道称礼来即将与其达成收购协议
老虎资讯综合 · 01-07
美股夜盘 | SanDisk续涨2%，Strategy涨近7%；Ventyx涨超66%，报道称礼来即将与其达成收购协议
生物医药公司Ventyx盘后股价飙升60%，据报获礼来超10亿美元收购
老虎资讯综合 · 01-07
生物医药公司Ventyx盘后股价飙升60%，据报获礼来超10亿美元收购
Ventyx Biosciences, Inc. 修订第二阶段 Rp 试验中期分析的顶线数据发布指导至2026年第一季度
美股速递 · 2025-12-02
Ventyx Biosciences, Inc. 修订第二阶段 Rp 试验中期分析的顶线数据发布指导至2026年第一季度
Ventyx Biosciences 第三季度每股收益为 -0.32 美元
投资观察 · 2025-11-20
Ventyx Biosciences 第三季度每股收益为 -0.32 美元
Ventyx Biosciences公布2025年第三季度财报，并强调近期企业进展
美股速递 · 2025-11-07
Ventyx Biosciences公布2025年第三季度财报，并强调近期企业进展
Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.30%报6.95美元
市场透视 · 2025-10-24
Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.30%报6.95美元
异动解读 | Ventyx Biosciences股价夜盘大涨5.15%，口服药物试验结果利好
异动解读 · 2025-10-24
异动解读 | Ventyx Biosciences股价夜盘大涨5.15%，口服药物试验结果利好
异动解读 | 万替生物科技股价夜盘大跌8.33%，此前因积极临床试验结果大涨
异动解读 · 2025-10-24
异动解读 | 万替生物科技股价夜盘大跌8.33%，此前因积极临床试验结果大涨
Replimune Group, Inc.盘中异动 早盘股价大涨5.06%报8.72美元
市场透视 · 2025-10-23
Replimune Group, Inc.盘中异动 早盘股价大涨5.06%报8.72美元
加载更多
公司概况
公司名称：
Ventyx Biosciences, Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Ventyx Biosciences, Inc.于2018年11月21日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于为数百万患有炎症性疾病和自身免疫性疾病的患者开发新疗法。该公司相信，他们有选择性地调节关键免疫靶点以创造差异化药物的能力将使他们有可能破坏成熟的价值数十亿美元的商业市场，并使他们成为免疫学市场的领导者。
发行价格：
--
{"stockData":{"symbol":"VTYX","market":"US","secType":"STK","nameCN":"Ventyx Biosciences, Inc.","latestPrice":13.86,"timestamp":1768931114006,"preClose":13.89,"halted":0,"volume":1026257,"delay":0,"changeRate":-0.002159827213822976,"floatShares":53555855,"shares":71750148,"eps":-1.499056,"marketStatus":"交易中","change":-0.03,"latestTime":"01-20 12:45:16 EST","open":13.86,"high":13.88,"low":13.85,"amount":14222970.679761,"amplitude":0.00216,"askPrice":13.86,"askSize":12400,"bidPrice":13.85,"bidSize":82436,"shortable":3,"etf":0,"ttmEps":-1.499056,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768942800000},"marketStatusCode":2,"adr":0,"listingDate":1634788800000,"exchange":"NASDAQ","adjPreClose":13.89,"preHourTrading":{"tag":"盘前","latestPrice":13.87,"preClose":13.89,"latestTime":"09:29 EST","volume":9210,"amount":127504.97148000001,"timestamp":1768919399999,"change":-0.02,"changeRate":-0.00144,"amplitude":0.00288},"postHourTrading":{"tag":"盘后","latestPrice":13.87,"preClose":13.89,"latestTime":"19:59 EST","volume":6191,"amount":85966.3899,"timestamp":1768611589114,"change":-0.02,"changeRate":-0.00144,"amplitude":0.00144},"volumeRatio":0.720642,"impliedVol":0.1735,"impliedVolPercentile":0.0199},"requestUrl":"/m/hq/s/VTYX","defaultTab":"news","newsList":[{"id":"1166716723","title":"Piper Sandler下调Ventyx Biosciences评级至中性 目标价降至14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166716723","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166716723?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:52","pubTimestamp":1767880335,"startTime":"0","endTime":"0","summary":"投资机构Piper Sandler将Ventyx Biosciences, Inc.的股票评级从\"增持\"下调至\"中性\"。同时，该机构将其目标股价从21美元大幅调降至14美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2601335004","title":"礼来将以12亿美元收购药物开发商Ventyx，加码自身免疫领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2601335004","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601335004?lang=zh_cn&edition=full","pubTime":"2026-01-08 10:10","pubTimestamp":1767838232,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d74e8a2f39481f1ab7fe8d5a08c4d07e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2168564495.EUR","LU0786609619.USD","BK4588","LU0096364046.USD","LU1093756168.USD","LU2750360641.GBP","VTYX","LU1064131342.USD","LU0823434740.USD","LU1720051108.HKD","LU2089984988.USD","LU2471134796.USD","LU2237443549.SGD","LU0354030438.USD","LU2491050071.SGD","LU2168564149.EUR","LU0889565916.HKD","LU2237443622.USD","SG9999015986.USD","LU2023250504.SGD","SG9999013999.USD","LU1814569148.SGD","IE0004445015.USD","LU0323591593.USD","LU2357305700.SGD","LU2552382058.USD","IE00BK4W5L77.USD","LU0266013472.USD","IE00BK4W5M84.HKD","LU2106854487.HKD","LU1061106388.HKD","IE00BJLML261.HKD","LU2361045086.USD","LU2237438978.USD","LU2264538146.SGD","LU0058720904.USD","LU2360106947.USD","LU0683600562.USD","LU1868837136.USD","LU1623119135.USD","LU0203201768.USD","LU1267930730.SGD","LU1917777945.USD","LU2112291526.USD","LU0097036916.USD","IE0009355771.USD","LU1548497426.USD","BK4585","LU1720051017.SGD","IE00BN29S564.USD","LU0109391861.USD","LU0256863811.USD","LU1974910355.USD","SG9999001176.SGD","LU0122379950.USD","SGXZ81514606.USD","LU2491050154.USD","LU1057294990.SGD","SG9999014906.USD","LU0106261372.USD","LU1983299246.USD","LU2168563687.JPY","IE00BFSS8Q28.SGD","LU2236285917.USD","LU1551013425.SGD","IE00B4R5TH58.HKD","LU2746668461.USD","LU2491049909.HKD","LU0353189763.USD","SGXZ51526630.SGD","LU1868836591.USD","LU1989771016.USD","LU2237443465.HKD","LU0823434583.USD","IE00B4JS1V06.HKD","BK4007","LU0353189680.USD","LU1035775433.USD","LU2237443895.HKD","LU0289739699.SGD","LU1712237335.SGD","LU2456880835.USD","BK4581","LU1291159041.SGD","LU1868836757.USD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU0094547139.USD","SG9999017495.SGD","LU2552382132.HKD","IE00BJJMRX11.SGD","LU2324357040.USD","LU1868836914.USD","LU0114720955.EUR","SGXZ57979304.SGD","IE00BKDWB100.SGD","LU0079474960.USD","LU0198837287.USD","IE00BFSS7M15.SGD","LU2461242641.AUD","LU2237443978.SGD","LU0471298694.HKD","LU0238689110.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU0109394709.USD","LU2602419157.SGD","BK4534","LU0320765992.SGD","LU1023059063.AUD","LU1232071149.USD","LU0432979614.USD","LU2471134523.USD","LU0823416689.USD","LU2211815571.USD","LU0385154629.USD","LU0882574055.USD","IE00B775H168.HKD","IE00BJJMRZ35.SGD","SGXZ31699556.SGD","LU2087625088.SGD","IE00B1XK9C88.USD","LU0061475181.USD","LU2471134952.CNY","IE0004445239.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU0320765059.SGD","SG9999014898.SGD","LU2265009873.SGD","LU1323610961.USD","LU2462157665.USD","SG9999001176.USD","SG9999014880.SGD","LU0256863902.USD","LU0471298777.SGD","LU2063271972.USD","SG9999015978.USD","LU0882574139.USD","LU2168564222.USD","LU0234572021.USD","IE00B2B36J28.USD","LU2108987350.USD","LU0820561909.HKD","LU1127390331.HKD","LU2552382215.SGD","BK4599","IE00BKPKM429.USD","GB00BDT5M118.USD","SG9999018857.SGD","LU1366192091.USD","LU2361044949.HKD","LU1868837300.USD","LU2168564065.EUR","LU2746668974.SGD","LU1280957306.USD","LU2750360997.AUD","LU1804176565.USD","LU0640476718.USD","LU2361044865.SGD","IE00B7KXQ091.USD","LU0203202063.USD","SGXZ99366536.SGD","LU0708995401.HKD","LU1988902786.USD","LLY","LU2471134879.HKD","LU0672654240.SGD","IE00BJJMRY28.SGD","LU2237443382.USD","IE00BWXC8680.SGD","BK4533","LU1551013342.USD","LU0354030511.USD","LU0006306889.USD","LU0456855351.SGD","LU0316494557.USD","LU0689472784.USD","LU0466842654.USD","LU1069344957.HKD","SG9999014914.USD","LU0943347566.SGD","SG9999015952.SGD","BK4516","LU0417517546.SGD","LU0787776722.HKD","LU0820561818.USD","LU1093756325.SGD","IE0002141913.USD","IE0005OL40V9.USD"],"gpt_icon":0},{"id":"2601133824","title":"礼来(LLY.US)确认以每股14美元收购Ventyx Biosciences(VTYX.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601133824","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601133824?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:56","pubTimestamp":1767833786,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来确认已同意以每股14美元的现金收购Ventyx Biosciences 。根据周三发布的一份声明，该交易的总股权价值约为 12 亿美元。该公司目前已销售多种治疗关节炎和银屑病等炎症性疾病的药物，包括Taltz，但Taltz的关键专利保护将在未来几年内到期。2024年，该公司以32亿美元收购了Morphic Therapeutics，获得了一种用于治疗炎症性肠病的实验性药物。此外，该公司还斥资24亿美元收购了Dice Therapeutics，后者是一家开发口服银屑病疗法的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2552382215.SGD","IE0009355771.USD","GB00BDT5M118.USD","LU0882574139.USD","LU1064131342.USD","LU0320765059.SGD","IE00B7KXQ091.USD","LU0238689110.USD","LU1548497426.USD","LU2491050154.USD","LU1712237335.SGD","SG9999017495.SGD","IE00BK4W5M84.HKD","LU0943347566.SGD","LU2471134523.USD","LU2552382058.USD","IE0004445015.USD","LU2089984988.USD","LU1057294990.SGD","IE00B775H168.HKD","LU0109394709.USD","LU2361044949.HKD","LU0417517546.SGD","LU2552382132.HKD","IE00B4JS1V06.HKD","VTYX","LU2602419157.SGD","LU0683600562.USD","IE00BKDWB100.SGD","LU1989771016.USD","LU0708995401.HKD","LU0786609619.USD","BK4599","LU2746668974.SGD","BK4581","LU0006306889.USD","LU2360106947.USD","LU2106854487.HKD","LU2237443549.SGD","LU1035775433.USD","LU0289739699.SGD","SGXZ99366536.SGD","LU0820561909.HKD","LU2087625088.SGD","LU2417539215.USD","IE00BFSS8Q28.SGD","LU0109391861.USD","LU1093756325.SGD","IE00BFSS7M15.SGD","LU1868836914.USD","LU0203201768.USD","LU1023059063.AUD","SG9999014906.USD","IE00B1BXHZ80.USD","LU2168564495.EUR","LU2236285917.USD","BK4533","LU0353189680.USD","LU0471298777.SGD","IE00BJJMRY28.SGD","LU1720051017.SGD","LU0353189763.USD","BK4516","LU2456880835.USD","LU2361045086.USD","LU1267930730.SGD","LU2750360997.AUD","LU1720051108.HKD","LU0672654240.SGD","LU0266013472.USD","LU0114720955.EUR","LU0354030511.USD","LU0689472784.USD","LU2168564065.EUR","LU2750360641.GBP","SG9999015986.USD","LU2112291526.USD","LU2357305700.SGD","LU0456855351.SGD","SG9999015978.USD","SG9999015952.SGD","LU2168564222.USD","LU1988902786.USD","LU2461242641.AUD","SG9999014914.USD","IE00BJJMRX11.SGD","SG9999015945.SGD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","LU1280957306.USD","LU1804176565.USD","IE0005OL40V9.USD","BK4588","LU1551013342.USD","SG9999001176.SGD","IE00BKPKM429.USD","IE0002141913.USD","LU1069344957.HKD","SG9999001176.USD","LU0097036916.USD","IE00B1XK9C88.USD","LU1093756168.USD","BK4534","LU0316494557.USD","SG9999014898.SGD","LU0203202063.USD","LU1868837300.USD","LU0256863811.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU0106261372.USD","LU0820561818.USD","LU2746668461.USD","LU1127390331.HKD","LU2211815571.USD","SG9999013999.USD","LU0432979614.USD","LU1366192091.USD","LU2023250504.SGD","LU1868836757.USD","LU0466842654.USD","LU1974910355.USD","LU2468319806.SGD","IE00BN29S564.USD","LU2237443465.HKD","LU0058720904.USD","LU0354030438.USD","LU0079474960.USD","SG9999018857.SGD","SG9999018865.SGD","LU2264538146.SGD","LU2361044865.SGD","LU0471298694.HKD","BK4007","LU0823434583.USD","LU0385154629.USD","LU1623119135.USD","LU0122379950.USD","LU1551013425.SGD","LU1232071149.USD","LU1983299246.USD","LU2168563687.JPY","LU1917777945.USD","LU1868836591.USD","LU2462157665.USD","LU2471134952.CNY","LU2168564149.EUR","LU2237438978.USD","SG9999014880.SGD","LU0061475181.USD","SGXZ31699556.SGD","LU0320765992.SGD","LU1061106388.HKD","LU2265009873.SGD","LU0787776722.HKD","IE0004445239.USD","LU0094547139.USD","IE00BK4W5L77.USD","LU1814569148.SGD","LU0256863902.USD","IE00BWXC8680.SGD","LU0882574055.USD","LU2491049909.HKD","LU1323610961.USD","LU0889565916.HKD","LU2237443895.HKD","LU0198837287.USD","SGXZ57979304.SGD","LU0234572021.USD","LU2237443978.SGD","IE00B4R5TH58.HKD","BK4585","IE00B2B36J28.USD","LLY","LU1868837136.USD","LU2108987350.USD","LU2237443382.USD","LU0640476718.USD","LU2324357040.USD","LU2491050071.SGD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU2237443622.USD","LU2471134879.HKD","LU0096364046.USD","LU0823434740.USD","LU0323591593.USD","SGXZ81514606.USD","IE00BJLML261.HKD","LU2471134796.USD","LU2063271972.USD"],"gpt_icon":1},{"id":"1116910979","title":"特定情形下合并终止，Ventyx Biosciences需向礼来支付4400万美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1116910979","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116910979?lang=zh_cn&edition=full","pubTime":"2026-01-08 06:07","pubTimestamp":1767823622,"startTime":"0","endTime":"0","summary":"根据协议条款，若在特定情况下合并交易终止，Ventyx Biosciences, Inc.将需向礼来公司支付高达4400万美元的终止费用。这一条款明确了双方在并购过程中的财务责任边界，凸显了交易执行的风险管控机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66eb5a09f43d3865bd83f1ee023dd147","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"1195755328","title":"礼来收购Ventyx Biosciences以推进炎症介导疾病口服疗法研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1195755328","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195755328?lang=zh_cn&edition=full","pubTime":"2026-01-08 05:19","pubTimestamp":1767820773,"startTime":"0","endTime":"0","summary":"礼来公司宣布将收购Ventyx Biosciences公司，此举旨在加速针对炎症介导疾病的口服治疗方案的开发进程。通过本次战略收购，礼来将获得Ventyx在炎症性疾病领域的新型口服疗法研发管线，进一步巩固其在免疫学治疗领域的领先地位。\n此次交易将整合两家公司在药物研发方面的专业优势，为患有炎症介导疾病的患者提供更多创新治疗选择。收购完成后，礼来计划持续推进Ventyx现有研发项目，重点关注口服疗法在炎症性疾病治疗中的应用潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"77fb275fa4af0a1883523469f5f5adba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"1123999203","title":"异动解读 | 礼来拟超10亿美元收购，Ventyx Biosciences盘中大涨36.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123999203","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123999203?lang=zh_cn&edition=full","pubTime":"2026-01-07 23:12","pubTimestamp":1767798745,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences（股票代码：VTYX）今日盘中大涨36.72%，引起了市场的广泛关注。消息面上，据《华尔街日报》等多家媒体报道，全球制药巨头礼来公司（Eli Lilly）正在就以超过10亿美元的价格收购Ventyx Biosciences进行深入谈判。此次收购旨在拓展礼来在免疫学领域的业务布局，Ventyx专注于研发治疗克罗恩病、类风湿性关节炎等炎症性疾病的药物。市场分析认为，这笔交易将为礼来带来丰富的产品管线，包括治疗炎症性肠病和帕金森症的药物。Ventyx目前还有一种治疗肥胖相关心血管疾病的实验性药物处于中期开发阶段，进一步增强了其吸引力。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9d938951d4e1d58a135a999ef2d5d12","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTYX"],"gpt_icon":0},{"id":"1142709093","title":"Ventyx Biosciences盘初一度涨超50%！据悉礼来接近达成以超10亿美元收购该公司的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1142709093","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142709093?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:41","pubTimestamp":1767796885,"startTime":"0","endTime":"0","summary":"1月7日，Ventyx Biosciences盘初一度涨超50%！据悉礼来接近达成以超10亿美元收购该公司的交易。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9d938951d4e1d58a135a999ef2d5d12","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX"],"gpt_icon":0},{"id":"2601752068","title":"美股异动｜礼来据称接近达成以超10亿美元收购Ventyx的交易，后者盘前飙升70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601752068","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601752068?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:15","pubTimestamp":1767777302,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9d938951d4e1d58a135a999ef2d5d12","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0943347566.SGD","VTYX","LU0471298694.HKD","LU2237443465.HKD","LU0823434583.USD","SG9999001176.SGD","LU0417517546.SGD","LU2168563687.JPY","LU1712237335.SGD","LU1035775433.USD","SG9999014906.USD","LU2063271972.USD","LU1804176565.USD","LU0316494557.USD","LU1232071149.USD","IE00B4R5TH58.HKD","LU0061475181.USD","LU2089984988.USD","LU2237443978.SGD","IE00BKPKM429.USD","LU0256863902.USD","LU1069344957.HKD","LU1093756168.USD","LU0094547139.USD","LU1093756325.SGD","SG9999017495.SGD","LU0683600562.USD","LU1064131342.USD","LU0820561909.HKD","LU1280957306.USD","LU2602419157.SGD","LU2361044949.HKD","LU2360106947.USD","LU2750360641.GBP","LU2357305700.SGD","LU1989771016.USD","SG9999014898.SGD","LU2237438978.USD","LU2237443622.USD","LU1551013342.USD","LU0058720904.USD","LU0672654240.SGD","LU0432979614.USD","LU1291159041.SGD","LU2361044865.SGD","LU2552382215.SGD","LU2168564149.EUR","SG9999018857.SGD","LU2087625088.SGD","LU1868836914.USD","BK4516","SGXZ81514606.USD","LU1988902786.USD","LU0109391861.USD","LU1868837300.USD","LU0114720955.EUR","LU2264538146.SGD","IE00B2B36J28.USD","LU2471134523.USD","BK4599","LU0456855351.SGD","IE00BFSS7M15.SGD","BK4007","LU0354030511.USD","LU0097036916.USD","IE00B1BXHZ80.USD","SG9999018865.SGD","LU0106261372.USD","LU0385154629.USD","LU0320765059.SGD","LU2552382132.HKD","LU2237443895.HKD","LU0203201768.USD","LU1323610961.USD","LU1917777945.USD","LU2462157665.USD","LU2168564222.USD","LU1623119135.USD","LU1023059063.AUD","LU2491050071.SGD","LU0708995401.HKD","IE00BK4W5M84.HKD","SG9999014914.USD","BK4534","IE00BJJMRZ35.SGD","LLY","IE00BJJMRY28.SGD","LU1720051108.HKD","SG9999013999.USD","LU0823416689.USD","LU2324357040.USD","LU1814569148.SGD","LU2468319806.SGD","IE00BWXC8680.SGD","IE00BJLML261.HKD","LU2491050154.USD","IE0005OL40V9.USD","LU0203202063.USD","LU0820561818.USD","LU0689472784.USD","SG9999015952.SGD","LU1868836757.USD","LU1061106388.HKD","LU2471134952.CNY","LU0234572021.USD","LU0238689110.USD","LU0256863811.USD","LU1983299246.USD","IE00BN29S564.USD","IE00B4JS1V06.HKD","LU1548497426.USD","LU2236285917.USD","LU1974910355.USD","SG9999015945.SGD","LU2746668974.SGD","LU2108987350.USD","BK4588","IE0004445015.USD","IE00BFSS8Q28.SGD","LU0006306889.USD","LU0096364046.USD","LU0266013472.USD","LU0320765992.SGD","LU0198837287.USD","IE00BKDWB100.SGD","LU0289739699.SGD","SG9999001176.USD","IE00BK4W5L77.USD","LU1720051017.SGD","LU0353189680.USD","LU2750360997.AUD","LU2471134796.USD","SGXZ31699556.SGD","IE0004445239.USD","LU0122379950.USD","IE0002141913.USD","LU1057294990.SGD","LU0786609619.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2417539215.USD","LU1551013425.SGD","SGXZ57979304.SGD","IE0009355771.USD","IE00B775H168.HKD","LU2491049909.HKD","LU2168564495.EUR","LU2471134879.HKD","IE00BJJMRX11.SGD","LU2746668461.USD","SG9999015978.USD","LU2106854487.HKD","LU2265009873.SGD","LU2552382058.USD","BK4533","LU0640476718.USD","LU0823434740.USD","LU0882574055.USD","LU0889565916.HKD","LU1868837136.USD","LU0353189763.USD","LU0079474960.USD","LU1868836591.USD","BK4581","LU1127390331.HKD","SG9999014880.SGD","LU0354030438.USD","LU2237443549.SGD","LU0323591593.USD","IE00B7KXQ091.USD","LU2211815571.USD","LU2361045086.USD","LU0466842654.USD","LU1366192091.USD","LU0471298777.SGD","BK4585","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2237443382.USD","LU0109394709.USD","LU2112291526.USD","SG9999015986.USD","LU0787776722.HKD","LU2456880835.USD","LU0882574139.USD","LU2168564065.EUR","IE00B1XK9C88.USD","LU1267930730.SGD","GB00BDT5M118.USD","LU2461242641.AUD","LU2023250504.SGD"],"gpt_icon":0},{"id":"1111765934","title":"异动解读 | 礼来拟超10亿美元收购，Ventyx Biosciences盘前大涨69.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111765934","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111765934?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:12","pubTimestamp":1767777149,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences（股票代码：VTYX）今日盘前股价大幅上涨69.25%，创下近期新高。消息面上，据《华尔街日报》等多家媒体报道，全球制药巨头礼来公司（Eli Lilly）正在就以超过10亿美元的价格收购Ventyx Biosciences进行深入谈判。此次收购旨在拓展礼来在免疫学领域的业务布局，Ventyx专注于研发治疗克罗恩病、类风湿性关节炎等炎症性疾病的药物。市场分析认为，这笔交易将为礼来带来丰富的产品管线，包括治疗炎症性肠病和帕金森症的药物。Ventyx目前还有一种治疗肥胖相关心血管疾病的实验性药物处于中期开发阶段，进一步增强了其吸引力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9d938951d4e1d58a135a999ef2d5d12","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTYX"],"gpt_icon":0},{"id":"1142034209","title":"盘前异动｜稀土概念股走强，Critical Metals涨超11%；贵金属板块普跌，金田跌近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142034209","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142034209?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:05","pubTimestamp":1767776730,"startTime":"0","endTime":"0","summary":"部分稀土概念股走高，Critical Metals涨超11%，MP Materials涨近3%，USA Rare Earth涨超2%；Strategy涨近6%，MSCI表示不会实施剔除数字资产财库公司的方案；Mobileye涨超10%，将以9亿美元收购机器人公司Mentee Robotics；Ventyx Biosciences涨超70%，礼来即将达成收购该公司，收购金额超10亿美元；Momentus涨超18%，宣布以纳斯达克规则下市价完成500万美元私募配售，获单一机构投资者认购；Aurora Innovation涨超10%，亚马逊与Aumovio合作，加速自动驾驶卡车的部署。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7f92605a0656b34a9917a93fe36d6e17","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSTR","VTYX","CRML"],"gpt_icon":0},{"id":"2601584267","title":"美股异动｜Ventyx Biosciences夜盘飙升66%，据称公司将获礼来以超10亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2601584267","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601584267?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:15","pubTimestamp":1767748514,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"77fb275fa4af0a1883523469f5f5adba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2552382132.HKD","IE00BJT1NW94.SGD","LU1366192091.USD","LU0683600562.USD","LU0198837287.USD","LU1814569148.SGD","LU2491050071.SGD","LU1989771016.USD","LU2168564065.EUR","IE0005OL40V9.USD","LU0109391861.USD","LU1291159041.SGD","IE00BKPKM429.USD","LU1061106388.HKD","LU0471298694.HKD","LU1868836591.USD","IE0009355771.USD","IE0004445239.USD","LU2357305700.SGD","SGXZ51526630.SGD","BK4533","LU0256863902.USD","SG9999001176.SGD","SG9999015986.USD","LU1267930730.SGD","LU0708995401.HKD","LU1551013425.SGD","LU2063271972.USD","LU2237438978.USD","LU1548497426.USD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0114720955.EUR","IE00B1BXHZ80.USD","LU0640476718.USD","LU2265009873.SGD","LU1093756168.USD","LU0471298777.SGD","LU1064131342.USD","IE00B1XK9C88.USD","LU0096364046.USD","LU2106854487.HKD","LU0109394709.USD","LU1917777945.USD","SG9999015952.SGD","LU2471134523.USD","SG9999018865.SGD","LU0882574055.USD","LU1868837136.USD","LU1093756325.SGD","LU1232071149.USD","SGXZ81514606.USD","LU1069344957.HKD","SG9999015978.USD","LU0456855351.SGD","LU0122379950.USD","LU1551013342.USD","LU2361045086.USD","LU0466842654.USD","LU2417539215.USD","LU2112291526.USD","LU0058720904.USD","BK4516","LU2087625088.SGD","LU0354030438.USD","SG9999018857.SGD","LU2168563687.JPY","SG9999014898.SGD","LU1983299246.USD","LU2211815571.USD","LU1988902786.USD","LU0823434583.USD","LU1804176565.USD","LU0094547139.USD","LU0882574139.USD","LU1868836757.USD","BK4599","LU0786609619.USD","LU2324357040.USD","LU1868837300.USD","LU2168564149.EUR","LU0823434740.USD","IE00B2B36J28.USD","LU2491049909.HKD","SGXZ99366536.SGD","LU0203202063.USD","LU1712237335.SGD","LU2746668974.SGD","IE00BK4W5M84.HKD","SGXZ31699556.SGD","LU2237443895.HKD","VTYX","IE00BN29S564.USD","LU1974910355.USD","LU1023059063.AUD","SG9999001176.USD","IE00B775H168.HKD","LU0354030511.USD","LU2750360997.AUD","LU2108987350.USD","BK4581","LU2168564495.EUR","LU2237443382.USD","IE00BFTCPJ56.SGD","LU0353189680.USD","IE00BJJMRX11.SGD","SG9999014880.SGD","IE00BJLML261.HKD","LU0266013472.USD","LU1280957306.USD","IE00BFSS8Q28.SGD","LU0289739699.SGD","LU2264538146.SGD","LU0203201768.USD","LU1323610961.USD","LU2023250504.SGD","LU2237443465.HKD","LU2361044865.SGD","LU2461242641.AUD","LU2168564222.USD","IE00BJJMRY28.SGD","LU0417517546.SGD","LU2468319806.SGD","LU2361044949.HKD","LU0787776722.HKD","LU0672654240.SGD","LU0238689110.USD","LU1720051017.SGD","BK4007","IE00BJJMRZ35.SGD","LU0316494557.USD","LU1035775433.USD","LU1057294990.SGD","SG9999014906.USD","LU0106261372.USD","LU0823416689.USD","LU2456880835.USD","LU2237443549.SGD","LU2236285917.USD","LU2237443978.SGD","LU0320765059.SGD","LU0256863811.USD","LU2746668461.USD","BK4588","LU0323591593.USD","LLY","LU0689472784.USD","IE00BK4W5L77.USD","LU1623119135.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU0097036916.USD","LU2471134796.USD","IE00B7KXQ091.USD","LU0943347566.SGD","LU2360106947.USD","LU0820561909.HKD","LU2750360641.GBP","BK4585","GB00BDT5M118.USD","LU2237443622.USD","BK4534","LU1127390331.HKD","IE00B4JS1V06.HKD","LU2471134879.HKD","SG9999017495.SGD","LU0079474960.USD","LU2462157665.USD","IE00BFSS7M15.SGD","LU2471134952.CNY","LU0061475181.USD","LU0006306889.USD","LU2602419157.SGD","SG9999015945.SGD","LU0353189763.USD","SG9999013999.USD","LU0889565916.HKD","LU2491050154.USD","IE00BWXC8680.SGD","LU2552382058.USD","SGXZ57979304.SGD","LU1868836914.USD","LU2552382215.SGD","IE0004445015.USD","LU0234572021.USD","LU0320765992.SGD","IE0002141913.USD","LU1720051108.HKD","SG9999014914.USD","LU0385154629.USD","LU0432979614.USD"],"gpt_icon":0},{"id":"1106027002","title":"美股夜盘 | SanDisk续涨2%，Strategy涨近7%；Ventyx涨超66%，报道称礼来即将与其达成收购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1106027002","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106027002?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:04","pubTimestamp":1767747865,"startTime":"0","endTime":"0","summary":"1月7日，美股夜盘时段，存储概念股SanDisk续涨2%，其隔夜股价暴涨27%。Strategy涨近7%，MSCI暂不实施剔除数字资产财库公司方案。Ventyx涨超66%，报道称礼来即将与其达成收购协议，收购金额超10亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"77fb275fa4af0a1883523469f5f5adba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSTR","SNDK","VTYX"],"gpt_icon":0},{"id":"1139091135","title":"生物医药公司Ventyx盘后股价飙升60%，据报获礼来超10亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1139091135","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139091135?lang=zh_cn&edition=full","pubTime":"2026-01-07 07:31","pubTimestamp":1767742304,"startTime":"0","endTime":"0","summary":"据华尔街日报报道，礼来即将与专门研发治疗炎症性疾病药物的 $Ventyx Biosciences, Inc.(VTYX)$ 达成收购协议，交易金额可能超过 10 亿美元。受此消息推动，Ventyx Biosciences的股价在盘后交易中上涨了超过60%。","market":"us","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"77fb275fa4af0a1883523469f5f5adba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","LLY"],"gpt_icon":0},{"id":"1141554398","title":"Ventyx Biosciences, Inc. 修订第二阶段 Rp 试验中期分析的顶线数据发布指导至2026年第一季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1141554398","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141554398?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:04","pubTimestamp":1764677057,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences, Inc. 修订第二阶段 Rp 试验中期分析的顶线数据发布指导至2026年第一季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"1103972831","title":"Ventyx Biosciences 第三季度每股收益为 -0.32 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103972831","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103972831?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:02","pubTimestamp":1763571773,"startTime":"0","endTime":"0","summary":"11月6日 - Ventyx Biosciences 第三季度运营费用为 2487.4万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"1198420202","title":"Ventyx Biosciences公布2025年第三季度财报，并强调近期企业进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1198420202","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198420202?lang=zh_cn&edition=full","pubTime":"2025-11-07 05:03","pubTimestamp":1762462995,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences公布2025年第三季度财报，并强调近期企业进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2578521118","title":"Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.30%报6.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578521118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578521118?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:33","pubTimestamp":1761312831,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时33分，Ventyx Biosciences, Inc.股票出现异动，股价大幅拉升5.30%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于推进新疗法，以帮助数百万患有炎症性疾病、自身免疫疾病以及神经退行性疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213351a6cc308d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213351a6cc308d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":1},{"id":"1102173291","title":"异动解读 | Ventyx Biosciences股价夜盘大涨5.15%，口服药物试验结果利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1102173291","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102173291?lang=zh_cn&edition=full","pubTime":"2025-10-24 12:52","pubTimestamp":1761281566,"startTime":"0","endTime":"0","summary":"生物科技公司Ventyx Biosciences, Inc.在周五夜盘交易中股价大涨5.15%，引发投资者广泛关注。据报道，Ventyx Biosciences的一款口服药物在临床试验中表现出色，成功降低了心脏病风险指标。此前，Ventyx Biosciences的股票在常规交易时段就已经上涨了92.7%，显示出市场对该公司前景的乐观预期。这一重大突破不仅有望为心脏病患者带来新的治疗选择，也彰显了Ventyx Biosciences在生物制药领域的创新能力。投资者对这一潜在的市场机遇反应积极，推动公司股价在盘后继续攀升。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTYX"],"gpt_icon":0},{"id":"1138119942","title":"异动解读 | 万替生物科技股价夜盘大跌8.33%，此前因积极临床试验结果大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1138119942","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138119942?lang=zh_cn&edition=full","pubTime":"2025-10-24 08:02","pubTimestamp":1761264152,"startTime":"0","endTime":"0","summary":"万替生物科技股票在周四夜盘交易中出现大幅下跌，跌幅高达8.33%，引发市场关注。据悉，万替生物科技的股价在当天早些时候曾飙升102.6%，创下近两年来的最高价。这一涨势是由该公司宣布其口服药物VTX3232在临床试验中取得积极结果所推动。然而，尽管早盘表现强劲，万替生物科技的股价在夜盘交易中却出现显著回落。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTYX"],"gpt_icon":0},{"id":"2577652535","title":"Replimune Group, Inc.盘中异动 早盘股价大涨5.06%报8.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577652535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577652535?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:42","pubTimestamp":1761226940,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时42分，Replimune Group, Inc.股票出现波动，股价急速上涨5.06%。截至发稿，该股报8.72美元/股，成交量45.7567万股，换手率0.59%，振幅4.23%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Replimune Group, Inc.公司简介：Replimune Group Inc 是一家临床阶段的生物技术公司。消息层面，截至21时42分，《Leerink Partners上调Replimune至买入评级，上调目标价至13美元》资讯为影响Replimune Group, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321422094d9d68b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321422094d9d68b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","REPL","BK4139","VTYX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.ventyxbio.com","stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.8062},{"period":"3month","weight":2.5434},{"period":"6month","weight":3.3886},{"period":"1year","weight":6.3492},{"period":"ytd","weight":0.5382}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ventyx Biosciences, Inc.于2018年11月21日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于为数百万患有炎症性疾病和自身免疫性疾病的患者开发新疗法。该公司相信，他们有选择性地调节关键免疫靶点以创造差异化药物的能力将使他们有可能破坏成熟的价值数十亿美元的商业市场，并使他们成为免疫学市场的领导者。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.081975},{"month":2,"riseRate":0.5,"avgChangeRate":0.472556},{"month":3,"riseRate":0.25,"avgChangeRate":-0.139982},{"month":4,"riseRate":0.75,"avgChangeRate":0.007413},{"month":5,"riseRate":0.75,"avgChangeRate":0.169529},{"month":6,"riseRate":0.25,"avgChangeRate":-0.151975},{"month":7,"riseRate":1,"avgChangeRate":0.16945},{"month":8,"riseRate":0.25,"avgChangeRate":0.018158},{"month":9,"riseRate":0.75,"avgChangeRate":0.25535},{"month":10,"riseRate":0.25,"avgChangeRate":0.269009},{"month":11,"riseRate":0.4,"avgChangeRate":-0.114905},{"month":12,"riseRate":0.6,"avgChangeRate":0.00109}],"exchange":"NASDAQ","name":"Ventyx Biosciences, Inc.","nameEN":"Ventyx Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ventyx Biosciences, Inc.,VTYX,Ventyx Biosciences, Inc.股票,Ventyx Biosciences, Inc.股票老虎,Ventyx Biosciences, Inc.股票老虎国际,Ventyx Biosciences, Inc.行情,Ventyx Biosciences, Inc.股票行情,Ventyx Biosciences, Inc.股价,Ventyx Biosciences, Inc.股市,Ventyx Biosciences, Inc.股票价格,Ventyx Biosciences, Inc.股票交易,Ventyx Biosciences, Inc.股票购买,Ventyx Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}